• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

C2N Diagnostics - Articles and news items

FDA orphan drug designation for C2N-8E12 for the treatment of progressive supranuclear palsy

Industry news / 20 July 2015 / Victoria White

The US FDA has granted C2N-8E12 (ABBV-8E12) an orphan drug designation for the treatment of progressive supranuclear palsy (PSP)…

 

Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringWATCH NOW
+ +